HS Code:
N-{2,4-Dichloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]phenyl}methanesulfonamide, commonly known as Sulfentrazone (CAS No. 122836-35-5), is a selective herbicide used primarily in agriculture to control broadleaf weeds and grasses in crops such as soybeans, sugarcane, and turf. Classified under HS Code 2935.90.75, it belongs to the category of sulfonamides and their derivatives. Sulfentrazone works by inhibiting protoporphyrinogen oxidase, an enzyme essential for chlorophyll synthesis in plants, leading to weed death. It is widely used due to its effectiveness and relatively low application rates.
Total Trade Volume
Approximately $150 million USD
Data from 2022
Source
Estimated data from UN Comtrade, ITC Trade Map, and industry reports
$60 million USD
40% of global trade of total trade
Increasing
$30 million USD
20% of global trade of total trade
Increasing
$25 million USD
17% of global trade of total trade
Stable
$15 million USD
10% of global trade of total trade
Increasing
$10 million USD
7% of global trade of total trade
Stable
Average Rate
5.5% ad valorem
Highest Rate
10% (in certain developing markets with protective agricultural policies)
Lowest Rate
0% (under free trade agreements such as USMCA or EU trade deals)
Increasing demand for herbicides in precision agriculture
Growth in Sulfentrazone usage due to its compatibility with sustainable farming practices and low dosage requirements
2021-2023
Shift towards bio-based and eco-friendly alternatives
Potential threat to Sulfentrazone market share as regulatory bodies push for greener agrochemicals
2022-2023
Rising agricultural output in South America
Higher demand for Sulfentrazone in soybean and sugarcane cultivation, especially in Brazil and Argentina
2020-2023
Sulfentrazone received renewed approval for use in the European Union under stricter environmental guidelines, boosting confidence in its safety profile.
March 2023
Positive for exporters to EU markets, though compliance costs may rise due to stringent regulations.
Key patents for Sulfentrazone formulations expired in several regions, leading to increased production of generic versions by manufacturers in India and China.
January 2022
Reduction in prices due to competition, benefiting farmers but squeezing margins for original producers.
Studies highlighting potential groundwater contamination risks associated with Sulfentrazone led to temporary usage restrictions in certain U.S. states.
September 2022
Negative short-term impact on sales in affected regions, with potential for broader regulatory scrutiny.